Skip to content
ClinCalc Pro
Menu
Penicillin (amidinopenicillin)

Pivmecillinam hydrochloride

Brand names: Selexid

Used in: Urinary Tract Infection

An oral prodrug of mecillinam, a penicillin-class antibacterial used as a first-line option for uncomplicated lower urinary tract infection.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

After absorption it is hydrolysed to mecillinam, which binds penicillin-binding protein 2 to disrupt cell-wall synthesis, giving activity predominantly against Gram-negative urinary pathogens such as Escherichia coli.

Prescribing in practice

  • Although a penicillin, it should be avoided in patients with penicillin hypersensitivity, so allergy status must be checked before prescribing.
  • It is intended for lower urinary tract infection and, like other oral pivalate prodrugs, is not suitable for prolonged or repeated courses owing to the risk of carnitine depletion.
  • Take with adequate fluids while seated or standing to reduce the risk of oesophageal irritation, and avoid in conditions causing oesophageal obstruction or stasis.

Monitoring

No routine laboratory monitoring is required for short treatment courses; reassess if symptoms do not resolve or recur.

Counselling the patient

  • Take the tablets with plenty of water and complete the full course.
  • Tell us if you have ever had an allergic reaction to penicillin.
  • Seek advice if your symptoms do not improve within a couple of days or if you develop a rash.

Evidence & guidelines

NICE guidance lists pivmecillinam as a first-line antibiotic option for uncomplicated lower urinary tract infection.

Reference: NICE NG109; UKHSA; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.